1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction
(
- Contribution to journal › Article
- 2018
-
Mark
Predictive Value of High-Sensitivity Troponin T for Systolic Dysfunction and Infarct Size (Six Months) After ST-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
No benefit of ticagrelor pretreatment compared with treatment during percutaneous coronary intervention in patients with ST-segment⇓elevation myocardial infarction undergoing primary percutaneous coronary intervention
(
- Contribution to journal › Article
- 2015
-
Mark
β-Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study.
(
- Contribution to journal › Article
-
Mark
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
(
- Contribution to journal › Article
- 2014
-
Mark
A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI.
(
- Contribution to journal › Article
-
Mark
Delay From First Medical Contact to Primary PCI and All-Cause Mortality: A Nationwide Study of Patients With ST-Elevation Myocardial Infarction.
(
- Contribution to journal › Article
-
Mark
Anemia in the general population: prevalence, clinical correlates and prognostic impact.
(
- Contribution to journal › Article
-
Mark
Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction.
(
- Contribution to journal › Article
- 2013
-
Mark
Acute right ventricular failure caused by concomitant coronary and pulmonary embolism: successful treatment with endovascular coronary and pulmonary thrombectomy.
(
- Contribution to journal › Article